logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
A

Audrey Mailliez

centre oscar lambret
H指数:29
被引数:4,733

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinical features associated with exceptional response on first-line anti-HER2-based therapy for metastatic breast cancer: real-world data from the ESME national cohort

与转移性乳腺癌一线抗HER2为基础治疗中表现出非凡疗效相关的临床特征：来自ESME国家队列的真实世界数据

Breast
IF7.9
2026-10-130
OA
Thomas Grinda; Matthieu Carton; Stefania Morganti; Audrey Mailliez; Christelle Levy; Thierry Petit; Thomas Bachelot; Monica Arnedos; Véronique Diéras; Vincent Massard; Florence Dalenc; Isabelle Desmoulins; Jean-Yves Pierga; Anthony Gonçalves; Caroline Bailleux; Jean-Sebastien Frenel; Lise Bosquet; Heather A. Parsons; William Jacot; Nancy U. Lin
Chemotherapy outcomes in human epidermal growth factor receptor 2-low, hormone receptor-positive metastatic breast cancer: Insights from the French multicenter ESME database

人表皮生长因子受体2低表达、激素受体阳性转移性乳腺癌的化疗结局：来自法国多中心ESME数据库的见解

Breast
IF7.9
2026-09-270
OA
William Jacot; Pauline Macouillard; Suyuan Zhang; Danalyn Byng; Shannon Hunter; Vincent Massard; Jean-Sébastien Frenel; David Pérol; Etienne Brain; Audrey Mailliez; Thomas Bachelot; Monica Arnedos; Lise Bosquet; Véronique Diéras
Updated Results of the POSITIVE (Pregnancy Outcome and Safety of Interrupting Therapy for Women with Endocrine Responsive Breast Cancer) Trial

POSITIVE试验（女性内分泌敏感性乳腺癌中断治疗的妊娠结局与安全性）最新结果

Annals of Oncology
IF65.4
2026-05-280
PRE
Olivia Pagani; Samuel M. Niman; Monica Ruggeri; Fedro A. Peccatori; Hatem A. Azim; Marco Colleoni; Cristina Saura; Chikako Shimizu; Anna Barbro Sætersdal; Judith R. Kroep; Ellen Warner; Frédéric Amant; Audrey Mailliez; Halle C.F. Moore; Manuel Ruiz-Borrego; Janice M. Walshe; Virginia F. Borges; Andrea Gombos; Akemi Kataoka; Christine Rousset-Jablonski
Characteristics, treatment and survival of older patients with metastatic triple negative breast cancer from the ESME mBC real-world national cohort: a comparison with younger women

老年转移性三阴性乳腺癌患者的特征、治疗及生存情况：基于ESME mBC真实世界全国队列研究，并与年轻女性进行比较

The Breast
IF0
2026-05-220
OAAI
Mathilde Mairé; Fanny Bouteiller; Camille Chakiba; William Jacot; Romain Geiss; Mony Ung; Anthony Goncalves; Jean-Sébastien Frenel; Caroline Bailleux; Christophe Perrin; Vincent Massard; Audrey Mailliez; Christelle Jouannaud; François Cherifi; Thierry Petit; Catherine Terret; Alessandro Viansone; Lise Bosquet; Angéline Galvin
Characteristics and outcomes of patients with HER2-negative metastatic breast cancers with low expression of estrogen and progesterone receptors in the multicenter ESME cohort.

HER2阴性低表达雌激素和孕激素受体转移性乳腺癌患者的特征和结局：多中心ESME队列研究

The Breast
IF0
2026-05-180
OAAI
Marie Alexandre; Eva Teruel; Florence Dalenc; Thibaut de la Motte Rouge; Etienne Brain; Vincent Massard; Monica Arnedos; Audrey Mailliez; Jean-Marc Ferrero; Thomas Bachelot; Isabelle Desmoulins; Marie-Ange Mouret-Reynier; Christelle Levy; Antony Gonçalves; Anca Berghian; Thierry Petit; Jean-Sébastien Frenel; Anne-Laure Martin; Thomas Grinda; William Jacot
Recent treatment and survival trends in older versus younger women with HR-positive HER2-negative metastatic breast cancer in the real-life multicenter French ESME cohort

老年与年轻HR阳性HER2阴性转移性乳腺癌女性患者真实世界多中心法国ESME队列中的近期治疗与生存趋势

European Journal of Cancer
IF7.1
2025-12-050
PRE
Fanny Bouteiller; Sophie Gourgou; Michaël Bringuier; Angéline Galvin; Audrey Mailliez; Nicolas Bertrand; Mony Hung; Jean-Sébastien Frenel; Vincent Massard; Thomas Bachelot; Carole Plumio; Anthony Gonçalves; Christelle Levy; Lise Bosquet; William Jacot; Suzette Delaloge; Thomas Grinda; Carine Bellera
PROMENADE: pembrolizumab for early ER-low/HER2-negative breast cancer, real-world French cohort

PROMENADE研究：早期ER低表达/HER2阴性乳腺癌患者接受pembrolizumab治疗的真实世界法国队列研究

ESMO Open
IF8.3
2025-11-250
OAAI
F. Cherifi; L. Cabel; C. Bousrih; E. Volant; F. Dalenc; B. Mery; M. Auvray Kuentz; A. Mailliez; S. Ladoire; A. Tassin de Nonneville; M. Alexandre; L. Benistant; M. Leheurteur; C. Bailleux; M. Debled; J.-S. Frenel; D. Loirat; E. Bastien; Q. Aussedat; F.C. Bidard
Letrozole to prevent breast cancer in postmenopausal women with BRCA1/2 mutations (LIBER study)

来曲唑预防携带BRCA1/2突变的绝经后女性乳腺癌（LIBER研究）

European Journal of Cancer
IF7.1
2025-11-070
PRE
Pascal Pujol; Lise Roca; Alain Lortholary; Christine Lasset; Louise Crivelli; Pascaline Berthet; Isabelle Tennevet; Thierry Petit; Nathalie Chabbert-Buffet; Paul Gesta; Claire Saule; Jean Chiesa; Tan Dat Nguyen; Audrey Mailliez; Nasrine Afdjei Callet; Catherine Noguès; Hélène Dreyfus; Capucine Delnatte; Fabienne Prieur; Laurence Gladieff; Olivier Ingster; Virginie Galibert; Jérôme Lemonnier; Suzette Delaloge
Corrigendum to “Hormonal factors predictive of fertility in patients with breast cancer interrupting adjuvant endocrine therapy to attempt pregnancy in POSITIVE trial” [The Breast 83 (2025) 104547]

勘误：“Hormonal factors predictive of fertility in patients with breast cancer interrupting adjuvant endocrine therapy to attempt pregnancy in POSITIVE trial” [The Breast 83 (2025) 104547]

The Breast
IF0
2025-09-220
PREAI
Isabelle Demeestere; Samuel M. Niman; Ann H. Partridge; Daniela S. Diego; Roswitha Kammler; Monica Ruggeri; Marco Colleoni; Chikako Shimizu; Cristina Saura; Karen A. Gelmon; Anna B. Saetersdal; Judith R. Kroep; Audrey Mailliez; Frederic Amant; Manuel Ruız-Borrego; Jeong Eon Lee; Akemi Kataoka; Janice M. Walshe; Junko Takei; Simona Borstnar; Virginia F. Borges; Christobel Saunders; Snezana Susnjar; Vesna Bjelic-Radisic; Fatima Cardoso; Jane Lowe Meisel; Jennifer F. Kawwass; Tanja Spanic; Sarra El-Abed; Martine Piccart; Larissa A. Korde; Aron Goldhirsch; Richard D. Gelber; Olivia Pagani; Hatem A. Azim; Fedro A. Peccatori
Evaluation of risk-reducing radical fimbriectomy followed by delayed oophorectomy in high-risk Women: A single-center retrospective study

高风险女性中风险降低性输卵管伞部切除术联合延迟卵巢切除术的评估：一项单中心回顾性研究

European Journal of Surgical Oncology
IF2.9
2025-09-180
PRE
Sophie Schoenen; Carlos Martinez Gomez; Camille Pasquesoone; Julie Alline; Mathilde Duchatelet; Séverine Risbourg; Audrey Mailliez; Aïcha Ben Miled; Mathilde Saint-Ghislain; Benjamin Serouart; Tom Fidlers; Lucie Bresson; Anne-Sophie Navarro; Marie-Cécile Le Deley; Fabrice Narducci
Real-world treatment patterns and effectiveness after disease progression on CDK4/6 inhibitors for HR-positive/HER2-negative metastatic breast cancer in the ESME-MBC cohort

CDK4/6抑制剂治疗后疾病进展的HR阳性/HER2阴性转移性乳腺癌患者中真实世界的治疗模式与疗效：ESME-MBC队列研究

ESMO Open
IF8.3
2025-09-170
PREAI
R. Varnier; D. Pérol; W. Jacot; A. Mailliez; V. Diéras; F. Dalenc; A. Gonçalves; C. Levy; M. Arnedos; J.-S. Frenel; C. Bailleux; V. Massard; E. Brain; B. Sauterey; A.-M. Savoye; L. Bosquet; J.-C. Thery; T. Petit; T. Bachelot; T. Grinda; I. Ray-Coquard
Hormonal factors predictive of fertility in patients with breast cancer interrupting adjuvant endocrine therapy to attempt pregnancy in POSITIVE trial

POSITIVE试验中，预测乳腺癌患者为尝试生育而中断辅助内分泌治疗时生育力的激素因素

breast
IF0
2025-07-260
OAAI
Isabelle Demeestere; Samuel M. Niman; Ann H. Partridge; Daniela S. Diego; Roswitha Kammler; Monica Ruggeri; Marco Colleoni; Chikako Shimizu; Cristina Saura; Karen A. Gelmon; Anna B. Saetersdal; Judith R. Kroep; Audrey Mailliez; Frederic Amant; Manuel Ruız-Borrego; Jeong Eon Lee; Akemi Kataoka; Janice M. Walshe; Junko Takei; Simona Borstnar; Virginia F. Borges; Christobel Saunders; Snezana Susnjar; Vesna Bjelic-Radisic; Fatima Cardoso; Jane Lowe Meisel; Jennifer F. Kawwass; Tanja Spanic; Sarra El-Abed; Martine Piccart; Larissa A. Korde; Aron Goldhirsch; Richard D. Gelber; Olivia Pagani; Hatem A. Azim; Fedro A. Peccatori
Differential benefit of adjuvant everolimus according to endocrine therapy backbone in the randomized UNIRAD trial

在随机UNIRAD试验中，根据内分泌治疗基础方案，辅助依维莫司的差异化获益

ESMO OPEN
IF8.3
2025-05-010
OAAI
Saint-Ghislain, M.; Chabaud, S.; Dalenc, F.; Allouache, D.; Cameron, D.; Martinez, M.; Grenier, J.; Barthelemy, P.; Brunt, M.; Kaluzinski, L.; Mailliez, A.; Legouffe, E.; Hardy-Bessard, A. -c.; Giacchetti, S.; Mouret-Reynier, M. -a.; Canon, J. -l.; Bliss, J.; Lemonnier, J.; Andre, F.; Bachelot, T.; Cottu, P.
Is capecitabine (CAPE) the best treatment (trt) option for estrogen receptor-positive (ER+) HER2-negative (HER2-) metastatic breast cancer (MBC) after progression on endocrine treatment (ET): An analysis of the ESME real-world database

卡培他滨（CAPE）是否是内分泌治疗（ET）进展后雌激素受体阳性（ER+）人表皮生长因子受体2阴性（HER2-）转移性乳腺癌（MBC）的最佳治疗（trt）选择：一项基于ESME真实世界数据库的分析

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Pflumio, C.; Carton, M.; Debled, M.; Cottu, P. H.; Leheurteur, M.; Dalenc, F.; Jacot, W.; Mailliez, A.; Sauterey, B.; Levy, C.; Kaderbhai, C.; Tredan, O.; Goncalves, A.; Uwer, L.; Robert, M.; Bailleux, C.; Cabel, L.; Delaloge, S.; Bosquet, L.; Petit, T.
Breastfeeding in women with hormone receptor-positive breast cancer who conceived after temporary interruption of endocrine therapy: Results from the POSITIVE trial

激素受体阳性乳腺癌女性在暂停内分泌治疗后成功受孕的母乳喂养情况：POSITIVE试验结果

ANNALS OF ONCOLOGY
IF65.4
2024-09-011
PRE
Azim, H. A., Jr.; Niman, S.; Partridge, A. H.; Ruggeri, M.; Colleoni, M. A.; Saura Manich, C.; Shimizu, C.; Satersdal, A.; Kroep, J. R.; Gelmon, K. A.; Amant, F.; Mailliez, A.; Moore, H.; Ferreiro, T.; El-abed, S.; Gelber, R. D.; Pagani, O.; Peccatori, F. A.
Prognosis and clinicopathological characteristics of HER2-negative metastatic breast cancers with low expression of hormone receptors: real world evidence from the French ESME cohort
CANCER RESEARCH
IF16.6
2024-05-020
PRE
Alexandre, Marie; Gauthier, Ludovic; Mailliez, Audrey; De La Motte Rouge, Thibault; Bachelot, Thomas; Arnedos, Monica; Dalenc, Florence; Brain, Etienne; Ferrero, Jean-Marc; Massard, Vincent; Desmoulins, Isabelle; Mouret-Reynier, Marie-Ange; Levy, Christelle; Goncalves, Anthony; Leheurteur, Marianne; Petit, Thierry; Frenel, Jean-Sebastien; Bosquet, Lise; Delaloge, Suzette; Jacot, William
Fertility preservation and assisted reproductive technologies (ART) in breast cancer (BC) patients (pts) interrupting endocrine therapy (ET) to attempt pregnancy
CANCER RESEARCH
IF16.6
2024-05-020
PRE
Azim, Hatem; Niman, Samuel; Partridge, Ann; Demeestere, Isabelle; Ruggeri, Monica; Colleoni, Marco; Saura, Cristina; Shimizu, Chikako; Saetersdal, Anna; Kroep, Judith; Mailliez, Audrey; Warner, Ellen; Borges, Virginia; Amant, Frederic; Gombos, Andrea; Kataoka, Akemi; Rousset-Jablonski, Christine; Borstnar, Simona; Takei, Junko; Lee, Jeong Eon; Walshe, Janice; Ruiz-Borrego, Manuel; Moore, Halle; Saunders, Christobel; Bjelic-Radisic, Vesna; Susnjar, Snezana; Cardoso, Fatima; Klar, Natalie; Spanic, Tanya; Ruddy, Kathryn; Piccart, Martine; Korde, Larissa; Goldhirsch, Aron; Gelber, Richard; Pagani, Olivia; Peccatori, Fedro Alessandro

研究方向

暂未获取到该数据
A
Anthony Gonçalvès
H 指数:61论文数:729被引数:1.9万
C
Christelle Lévy
H 指数:46论文数:389被引数:1.0万
F
Florence Dalenc
H 指数:55论文数:561被引数:1.5万
W
William Jacot
H 指数:51论文数:481被引数:1.7万
I
Isabelle Desmoulins
H 指数:24论文数:203被引数:3,980
M
Marc Debled
H 指数:42论文数:373被引数:8,117
J
Jean‐Sébastien Frenel
H 指数:38论文数:411被引数:8,126
T
Thomas Bachelot
H 指数:65论文数:556被引数:2.4万
T
Thierry Petit
H 指数:30论文数:187被引数:3,622
M
Marie‐Ange Mouret‐Reynier
H 指数:41论文数:194被引数:7,604